Conference
Atezolizumab plus bevacizumab versus lenvatinib as first-line systemic therapy for treatment of hepatocellular carcinoma in a real-world population: Outcomes from the HCC CHORD database.
Authors
Freeman M; Krishnan T; Lee CL; Dibajnia P; Ramjeesingh R; Vasconcelos JPS; Lyubetska H; Ding PQ; Lim HJ; Knox JJ
Volume
42
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
June 1, 2024
Name of conference
Special Clinical Science Symposia
Conference place
ELECTR NETWORK
Conference start date
May 29, 2024
Conference end date
May 29, 2024
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X